SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.
Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.
SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.
Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.
Change in Preferred Drug List Status for Antihyperuricemics Drug Class
Date: April 25, 2024
Attention: All Providers
Effective date: April 22, 2024
Call to action: Effective April 22, 2024, the Texas Health and Human Services (HHS) removed non-preferred status from brand name Mitigare products. This is in response to the discontinuation of the brand products Colcrys by the manufacturer.
The preferred status of the brand name Colcrys will not change to allow any remaining stock to be used.
How this impacts providers: The change will allow providers to prescribe the generic without requiring PDL prior authorization at this time and continue accessing necessary medication for their patients.
Please see below for the list of impacted drugs (of note, the approval is NDC-specific):
Preferred Medication NDC
Preferred Medication
Type of Change
Effective Date
59467031801
MITIGARE 0.6 MG CAPSULE
Brand now preferred
April 22,2024
59467031810
MITIGARE 0.6 MG CAPSULE
Brand now preferred
April 22,2024
59467031830
MITIGARE 0.6 MG CAPSULE
Brand now preferred
April 22,2024
Next step for Providers: Prescribers are encouraged to proactively obtain a prescription for the preferred alternatives to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.
